BIMI International Medical (BIMI International Medical) Interest Expense : $-1.09 Mil (TTM As of Sep. 2023)

View and export this data going back to 2006. Start your Free Trial

What is BIMI International Medical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. BIMI International Medical's interest expense for the three months ended in Sep. 2023 was $ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.09 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. BIMI International Medical's Operating Income for the three months ended in Sep. 2023 was $ -3.15 Mil. BIMI International Medical's Interest Expense for the three months ended in Sep. 2023 was $ -0.04 Mil. BIMI International Medical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BIMI International Medical Interest Expense Historical Data

The historical data trend for BIMI International Medical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical Interest Expense Chart

BIMI International Medical Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.09

-2.44

-3.43

BIMI International Medical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Interest Expense	Get a 7-Day Free Trial															-0.81	-0.99	-0.04	-0.04	-0.04

BIMI International Medical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.09 Mil.

BIMI International Medical (NAS:BIMI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BIMI International Medical's Interest Expense for the three months ended in Sep. 2023 was $-0.04 Mil. Its Operating Income for the three months ended in Sep. 2023 was $-3.15 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was $2.47 Mil.

BIMI International Medical's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

BIMI International Medical did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

BIMI International Medical (BIMI International Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (NAS:BIMI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010

Website

https://www.usbimi.com

BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

Executives

Ang Sammi Ean Seok	director	2658 VISTA MONTE CIRCLE, CHINO HILLS CA 91709
Fnu Oudom	director	7700 IRVINE CENTRE DRIVE, SUITE 800, IRVINE CA 92618
Xiaoping Wang	director	ROOM 4-6,NO.88-4 HUAYAN FIRST VILLAGE, SHAPINGBA DISTRICT, CHONGQING F4 400037
Baiqun Zhong	officer: CFO	1-7, NO.27, HUAYAN NEW VILLAGE, JIULONGPO DISTRICT, CHONGQING F4 400039
Zhang Tingting	director, officer: Chief Financial Officer	3708, FULI CENTER, NO.6 GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Song Tiewei	director	17 FLOOR, FULI CENTER NO.6,GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Yongquan Bi	10 percent owner	ROOM 3708, WANDA PLACE, 6 GANGWAN ROAD, ZHONGSHAN DISTRICT, DALIAN CITY, LIAONING PROVINCE F4 116001
Wang Lihua	director, 10 percent owner, officer: Chief Financial Officer	NO 4 4 12 58 BAJING ROAD, HEPING DISTRICT SHENYANG CITY, LIAONING PROVINCW F4 110003
Li Gang	director, 10 percent owner, officer: President and CEO	19B3 62 WEST HINHE ROAD, SHENHE DISTRICT SHENYANG CITY, LIAONING PROVINCE F4 110000
Jiuding Yan	director	C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Lesley Jin	director	C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Maclean John Coleman	director	112 E 4TH AVE, SUITE 206, OLYMPIA WA 98501
Zhongmin Wang	director	C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Jianxin Wang	director	C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021
Mia Kuang Ching	director	C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021